IPO Synopsis
| Invicta Diagnostic Ltd |
|---|
| Registered Office: 1 GF Plot 217 Ambavat Bhavan,N.M.Joshi Marg Delisle Road,Mumbai-400013, Maharashtra |
| Tel. No: 022 4971 0036 |
| Fax No: NA |
| Email: investors@pcdiagnostics.in |
| Website: www.pcdiagnostics.in |
| Initial public offering of up to 33,08,800 equity shares of face value of Rs. 10/- each ("Equity Shares") for cash at a price of Rs. [*] per equity share (including a premium of Rs. [*] per equity share) ("Issue price") aggregating to Rs. [*] crores ("the Issue"). The issue will constitute [*] % of the post-issue paid up equity share capital of the company. The issue includes a reservation of up to [*] equity shares aggregating to Rs. [*] crores (constituting up to [*] % of the post issue paid-up equity share capital of the company) for subscription by market maker ("Market Maker Reservation Portion"). The issue less the market maker reservation portion is hereinafter referred to as the "Net Issue". The issue and the net issue will constitute [*] % and [*] % respectively, of the post-issue paid-up equity share capital of the company. Price Band: Rs. 80/- to Rs. 85/- for equity share of face value of Rs. 10 each. The floor price is 8.00 times times the face value and cap price is 8.50 times of the face value of the equity shares. Bids can made for a minimum of 3,200 equity shares and in multiples of 1,600 equity shares thereafter. |
| Issue | Money Payable On | ||
|---|---|---|---|
| Opens On | Closes On | Application | |
| 01-Dec-2025 | 03-Dec-2025 | ₹80.00 - 85.00 | |
| Minimum Application for shares in Nos : 3200.0 | Further Multiples of :1600.0 |
|---|
| (₹ Cr) | Lead Managers to the Issue | |
|---|---|---|
| Project Cost | 0.00 | Socradamus Capital Pvt Ltd |
| Project Financed through Current Offer | 26.47 | |
| Post Issue Equity Share Capital | 12.57 | |
| Issue Price | 80.00 |
| Projects |
|---|
| Promoted By |
|---|
| Ketan Jayantilal Jain |
| Sanket Vinod Jain |
| Rohit Prakash Srivastava |
| Listing At |
|---|
| NSE - SME |
| Registrar To The Issue |
|---|
